Status:
RECRUITING
SARcopenia and Simplified Geriatric Assessment in Lymphoma Patients Undergoing CAR-T Cell Therapy: the FIL_SAR-CAR Project
Lead Sponsor:
Fondazione Italiana Linfomi - ETS
Collaborating Sponsors:
Kite, A Gilead Company
Conditions:
Non-hodgkin Lymphoma,B Cell
Eligibility:
All Genders
18+ years
Brief Summary
This is a multicenter prospective observational study lead by the FIL on sarcopenia and sGA as possible predictors of efficacy and toxicity outcomes in patients undergoing CAR-T cells treatment.
Eligibility Criteria
Inclusion
- Adult patients (≥ 18 years old).
- Patients with B-cell non-Hodgkin Lymphoma scheduled to received CAR-T cell product according to Agenzia Italiana del Farmaco (AIFA) indications and technical data sheet of the drug
- Availability of a 18F-FDG PET/CT scan or a full dose CT scan (without contrast media) pre-treatment with CART
- Written informed consent voluntarily provided
Exclusion
- Patients not fulfilling the eligibility criteria
Key Trial Info
Start Date :
April 18 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2026
Estimated Enrollment :
130 Patients enrolled
Trial Details
Trial ID
NCT06156774
Start Date
April 18 2024
End Date
July 1 2026
Last Update
December 8 2025
Active Locations (21)
Enter a location and click search to find clinical trials sorted by distance.
1
A.O. SS. Antonio e Biagio e Cesare Arrigo - S.C.D.U. Ematologia
Alessandria, Italy
2
AOU Ospedali Riuniti - Clinica di Ematologia
Ancona, Italy
3
Azienda Ospedaliera S .Giuseppe Moscati - S.C. Ematologia e Trapianto emopoietico
Avellino, Italy
4
IRCCS Centro di Riferimento Oncologico di Aviano - Divisione di Oncologia e dei Tumori immuto-correlati
Aviano, Italy